Detalles de la búsqueda
1.
Suppressed IgG4 class switching in dupilumab- and TNF inhibitor-treated patients after mRNA vaccination.
Allergy;
2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38439527
2.
Primary SARS-CoV-2 infection in patients with immune-mediated inflammatory diseases: long-term humoral immune responses and effects on disease activity.
BMC Infect Dis;
23(1): 332, 2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37198536
3.
Reducing scratching behavior in atopic dermatitis patients using the EMDR treatment protocol for urge: A pilot study.
Front Med (Lausanne);
10: 1101935, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37081840
4.
Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry.
JMIR Res Protoc;
12: e43230, 2023 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36995758
5.
Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations.
J Autoimmun;
135: 102984, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36621174
6.
Tralokinumab treatment for patients with moderate-to-severe atopic dermatitis in daily practice.
Clin Exp Dermatol;
48(5): 510-517, 2023 Apr 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702810
7.
Impact of the First SARS-CoV-2 Lockdown on Adherence to Biological Treatment in Patients with Immune-Mediated Inflammatory Diseases in the Netherlands.
Patient Prefer Adherence;
17: 167-174, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36698858
8.
Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases.
Ann Rheum Dis;
81(12): 1757-1766, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36357161
9.
EASI p-EASI: Predicting Disease Severity in Patients with Atopic Dermatitis Treated with Tralokinumab.
J Invest Dermatol;
142(12): 3335-3337.e1, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35843313
10.
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.
Lancet Rheumatol;
4(6): e417-e429, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35527808
11.
Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study.
Lancet Rheumatol;
4(5): e338-e350, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35317410
12.
Care for children with atopic dermatitis in the Netherlands during the COVID-19 pandemic: Lessons from the first wave and implications for the future.
J Dermatol;
48(12): 1863-1870, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34459024
13.
Shifting paradigms in the immunology of atopic dermatitis.
J Allergy Clin Immunol;
145(5): 1360-1362, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32179160
14.
Allopurinol Co-prescription Improves the Outcome of Azathioprine Treatment in Chronic Eczema.
Acta Derm Venereol;
98(3): 373-375, 2018 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-29136268
15.
EASI p-EASI: Utilizing a combination of serum biomarkers offers an objective measurement tool for disease severity in atopic dermatitis patients.
J Allergy Clin Immunol;
140(6): 1703-1705, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-28823810
16.
First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
J Dermatol Sci;
81(1): 66-8, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26547110
17.
Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization.
Blood;
115(5): 965-74, 2010 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-19996091
18.
Cyclosporin A treatment is associated with increased serum immunoglobulin E levels in a subgroup of atopic dermatitis patients.
Dermatitis;
18(3): 163-5, 2007 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-17725924
Resultados
1 -
18
de 18
1
Próxima >
>>